SC Filed 2021-04-06 Event — SEC 0001193125-21-107710 →

PERCEPTIVE ADVISORS LLC → Landos Biopharma, Inc.

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

7 filings by this filer

6 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other Filings by PERCEPTIVE ADVISORS LLC

Filed	Form	Issuer	Stake	Shares
2026-01-26	SCHEDULE	TRINITY BIOTECH PLC TRIB	9.90%	1,463,058,248	view →
2026-01-02	SCHEDULE	MeiraGTx Holdings plc MGTX	12.90%	10,441,562	view →
2025-02-21	SCHEDULE	Solid Biosciences Inc. SLDB	15.60%	11,934,679	view →
2025-02-14	SCHEDULE	TRINITY BIOTECH PLC TRIB	20.90%	85,800,000	view →
2025-01-31	SCHEDULE	Nautilus Biotechnology, Inc. NAUT	10.00%	12,594,211	view →
2022-07-01	SC	Athira Pharma, Inc. LONA	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →